Marika Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Marika Inc
TickerPVLA
CIK #0001583648
CUSIP697947109
SectorTrade & Services - Services-Business Services, Nec
Address2360 Corporate Circle Suite 400, Henderson, NV 89074
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Pieris Pharmaceuticals Inc 2019-11-20 32.0 M Exemption: 506(b) · Duration: One year or less · Commission: $796,062 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001583648] 10-K
[0001583648] 10-Q
[0001583648] 3
[0001583648] 4
[0001583648] 8-K
[0001583648] D
[0001583648] SC 13D
[0001583648] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
First Light Asset Management LLC Palvella Therapeutics Inc [2026-02-17] 0.0
Frazier Life Sciences Public Fund LP Palvella Therapeutics Inc [2025-01-08] 0.0
Kaupinen WES Palvella Therapeutics Inc [2024-12-20] 0.0
Suvretta Capital Management LLC Palvella Therapeutics Inc [2024-12-20] 0.0
Samsara Biocapital LP Palvella Therapeutics Inc [2024-12-20] 0.0
Dellora Investments LP Pieris Pharmaceuticals Inc [2024-08-07] 0.0
ADAR1 Capital Management LLC Pieris Pharmaceuticals Inc [2024-08-01] 10.5
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17] 10.4
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17] 10.4
Checkpoint Capital LP Pieris Pharmaceuticals Inc [2023-06-12] 6.0
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2023-05-22] 11.8
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2023-01-27] 5.4
Lynx1 Capital Management LP Pieris Pharmaceuticals Inc [2022-10-24] 5.1
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2022-01-27] 5.4
Citadel Advisors LLC Pieris Pharmaceuticals Inc [2021-07-06] 4.9
Astrazeneca PLC Pieris Pharmaceuticals Inc [2021-04-08] 5.66
Seagen Inc Pieris Pharmaceuticals Inc [2021-04-02] 6.2
Nussbaum Ran Pieris Pharmaceuticals Inc [2021-02-16] 6.4
BlackRock Inc Pieris Pharmaceuticals Inc [2020-02-07] 6.2
EcoR1 Capital LLC Pieris Pharmaceuticals Inc [2019-11-14] 8.8
Aquilo Capital Management LLC Pieris Pharmaceuticals Inc [2019-10-07] 5.1
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2016-06-17] 4.1
Lombard Odier Asset Management USA Corp Pieris Pharmaceuticals Inc [2016-02-16] 7.17
Tekla Capital Management LLC Pieris Pharmaceuticals Inc [2016-02-12] 0.7
Novo Nordisk A S Pieris Pharmaceuticals Inc [2016-01-28] 5.2
Global Life Bioventure IV SARL Pieris Pharmaceuticals Inc [2015-09-11] 6.25
Tompkins Mark N Pieris Pharmaceuticals Inc [2015-07-10] 5.6
OrbiMed Advisors LLC Pieris Pharmaceuticals Inc [2015-07-09] 18.8
Form 3/4/5 Filer 2011 - 2026
Palvella Therapeutics Inc
Pauls Matthew
Goin Kathleen
Korenberg Matthew E
Davis Todd C
Heron Elaine J
Doux John
Kiritsy Christopher P
Wessel Tadd S
Jenkins George M
Kline Ashley Hartmann
Martini Jeffrey S
Kaupinen Wes
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Dellora Investments LP
Geraghty James A
ADAR1 Partners LP
ADAR1 Capital Management LLC
Barbier Ann
Said Maya R
Sherman Matthew L
Kiener Peter A
Richman Michael
Bures Thomas
Kaufmann Hitto
Mousa Ahmed
Yoder Stephen S
Olwill Shane
Demuth Tim
Aquilo Capital Management LLC
Bizzari Jean-Pierre
Reine Allan
Matis Louis
Prelack Steven
OrbiMed Advisors LLC
OrbiMed Capital GP III LLC
Adams Julian
Isaly Samuel D
Khuong Chau Quang
Thibault Lance E
Knopf Claude
Deptula-Hicks Darlene M
Takke Christina
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 2,154 $0.00
Goin Kathleen
Common Stock
2026-03-18 Option exercise 2,154 $7.14 15,380
Goin Kathleen
Common Stock
2026-03-18 Option exercise 2,148 $9.08 19,504
Goin Kathleen
Common Stock
2026-03-18 Sell 1,730 $118.37 204,780
Goin Kathleen
Common Stock
2026-03-18 Sell 304 $119.08 36,200
Goin Kathleen
Common Stock
2026-03-18 Sell 2,268 $117.56 266,626
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 2,148 $0.00
Jenkins George M
Common Stock
2026-02-27 Buy 4,000 $125.00 500,000
Heron Elaine J
Common Stock
2026-02-27 Buy 2,400 $125.00 300,000
Goin Kathleen
Common Stock
2026-02-18 Option exercise 2,154 $7.14 15,380
Goin Kathleen
Common Stock
2026-02-18 Sell 1,276 $79.97 102,042
Goin Kathleen
Common Stock
2026-02-18 Sell 3,026 $79.16 239,538
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-02-18 Option exercise 2,148 $0.00
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-02-18 Option exercise 2,154 $0.00
Goin Kathleen
Common Stock
2026-02-18 Option exercise 2,148 $9.08 19,504
Korenberg Matthew E
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 44,123 $0.00
Martini Jeffrey S
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 64,318 $0.00
Kline Ashley Hartmann
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 38,517 $0.00
Kaupinen Wes
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 124,603 $0.00
Goin Kathleen
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 48,956 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 182 13,407,703
2025-12-31 145 10,050,735
2025-09-30 100 8,550,626
2025-06-30 66 5,919,649
2025-03-31 42 5,123,399
2024-12-31 34 4,033,115
Form 13F Holdings
Firm Period DFND Voting Shares
Aspiriant LLC [2026-06-30] SOLE 0 5,852
Spire Wealth Management [2026-06-30] SOLE 0 1,000
Eastern Bank [2026-06-30] DFND 52 52
Gamma Investing LLC [2026-06-30] DFND 37 37
Farther Finance Advisors LLC [2026-06-30] SOLE 0 13
Corecap Advisors LLC [2026-06-30] SOLE 0 11
Fortitude Family Office LLC [2026-06-30] SOLE 5 5
Hughes Financial Services LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com